Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients
Open Access
- 27 May 2021
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 41 (5)
Abstract
Purpose: ADME genes are genes involved in drug absorption, distribution, metabolism, and excretion (ADME). Previous studies report that expression levels of ADME-related genes correlate with prognosis of hepatocellular carcinoma (HCC) patients. However, the role of ADME gene expression on HCC prognosis has not been fully explored. The present study sought to construct a prediction model using ADME-related genes for prognosis of HCC. Methods: Transcriptome and clinical data were retrieved from The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC), which were used as training and validation cohorts, respectively. A prediction model was constructed using univariate Cox regression and Least Absolute Shrinkage and Selection Operator (LASSO) analysis. Patients were divided into high- and low-risk groups based on the median risk score. The predictive ability of the risk signature was estimated through bioinformatics analyses. Results: Six ADME-related genes (CYP2C9, ABCB6, ABCC5, ADH4, DHRS13, and SLCO2A1) were used to construct the prediction model with a good predictive ability. Univariate and multivariate Cox regression analyses showed the risk signature was an independent predictor of overall survival (OS). A single-sample gene set enrichment analysis (ssGSEA) strategy showed a significant relationship between risk signature and immune status. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses showed differentially expressed genes (DEGs) in the high- and low-risk groups were enriched in biological process (BP) associated with metabolic and cell cycle pathways. Conclusion: A prediction model was constructed using six ADME-related genes for prediction of HCC prognosis. This signature can be used to improve HCC diagnosis, treatment, and prognosis in clinical use.Keywords
This publication has 38 references indexed in Scilit:
- Identification of ADH4 as a novel and potential prognostic marker in hepatocellular carcinomaMedical Oncology, 2011
- Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY programExpert Review of Respiratory Medicine, 2011
- Functional significance of the ATP‐binding cassette transporter B6 in hepatocellular carcinomaMolecular Oncology, 2011
- The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancerCancer Biology & Therapy, 2011
- Hepatocellular carcinoma: a global viewNature Reviews Gastroenterology & Hepatology, 2010
- FOXP3+ regulatory T cells in the human immune systemNature Reviews Immunology, 2010
- Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cellsImmunobiology, 2009
- Cytokeratin 10 and Cytokeratin 19: Predictive Markers for Poor Prognosis in Hepatocellular Carcinoma Patients after Curative ResectionClinical Cancer Research, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Human Sulfotransferases and Their Role in Chemical MetabolismToxicological Sciences, 2005